Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
about
Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusionA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal VeinSCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusionIntravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis)Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography studyNovel approaches to retinal drug delivery.Influence of drug lipophilicity on drug release from sclera after iontophoretic delivery of mixed micellar carrier system to human sclera.Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.Evaluation of contrast sensitivity after single intravitreal triamcinolone injection for macular edema secondary to branch retinal vein occlusion.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Safety of intravitreal triamcinolone acetonide: an electrophysiologic and histopathological study in rabbits.A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety.
P2860
Q24242868-B56E4820-0C4F-4D69-8CB4-B9F94F4D97DEQ24646760-0D4BF566-7D94-4FAC-B581-EDA0619F9940Q33402708-DCDEC86E-CB2D-4823-ACF7-B834E33B690CQ33416826-37A2E3AB-BD80-44AA-9618-52AACB8142ACQ35956280-CD732595-473A-4A28-8804-3A199AFAE0A0Q36903801-8D3AFB8B-9E19-4ED7-8876-28519FD25093Q37274226-A3C876FB-2B2F-46CA-80A6-8489EF3EF385Q37393753-5822CEDE-33D5-4ADC-935E-CC03FD91D85BQ37556274-3639B53C-0B8A-4951-ABA3-95006D5CB71BQ37627442-A086C464-EE94-484A-AC33-65D8DB4C0FDEQ41895584-C79C7163-7419-4065-8FFC-0711516A38D7Q42881016-23323A6E-01B2-41FA-912F-38402F49039CQ52597568-13E49F0A-C63C-4D06-ADCF-2B9ED6BA97B9
P2860
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@ast
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@en
type
label
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@ast
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@en
prefLabel
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@ast
Intravitreal triamcinolone tre ...... nd hemiretinal vein occlusion.
@en
P2093
P1433
P1476
Intravitreal triamcinolone tre ...... and hemiretinal vein occlusion
@en
P2093
Gaetano R Barile
Harold Weissman
James M Klancnik
Joseph J Tseng
Lucian V Del Priore
Michael Weiss
Stanley Chang
William M Schiff
P304
P356
10.1097/00006982-200510000-00005
P50
P577
2005-10-01T00:00:00Z